tag:blogger.com,1999:blog-9098231416804954636.post9143219203264701730..comments2023-10-24T03:56:38.823-07:00Comments on Accumulating Assets: Sharebuilder DRIP Purchases- KMI, TEVA, CAT KMRAccumulating Assetshttp://www.blogger.com/profile/17775500122960073181noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-9098231416804954636.post-37642033809998675772013-11-13T22:19:08.518-08:002013-11-13T22:19:08.518-08:00Fast Weekly,
Thanks for stopping by.
I agree wit...Fast Weekly,<br /><br />Thanks for stopping by.<br /><br />I agree with you on TEVA. Its cheap, is shareholder friendly, and is the largest generic in the world with an aging western population to benefit from its products. Yet it just sits there. I do think patient shareholders will eventually be rewarded. And this one takes some serious patience.<br /><br />cheers,<br />AAAccumulating Assetshttps://www.blogger.com/profile/17775500122960073181noreply@blogger.comtag:blogger.com,1999:blog-9098231416804954636.post-83340554157184592002013-11-13T04:03:26.557-08:002013-11-13T04:03:26.557-08:00Hi AA,
I've been in and out of Teva over the l...Hi AA,<br />I've been in and out of Teva over the last few years. That one continues to disappoint me. It has so much promise, but I just can't figure out where it's going wrong. It is fundamentally a commodity business, which competes primarily on price, but generics are a growing field and Teva has an extensive distribution network. <br /><br />Good job with the DRIPs. I have several I've held for years and they have done really well over time.<br />-BryanFast Weeklyhttp://fastweekly.blogspot.comnoreply@blogger.com